Year of birth has a larger impact on obesity than genes alone, according to an analysis of the relationship between body mass index and an obesity-related gene variant.
Year of birth has a larger impact on obesity than genes alone, according to research published in Proceedings of the National Academy of Sciences.
According to an analysis of the participants of the Framingham Heart Study, as the year of birth of the participants increased, so did the correlation between the gene variant associated with obesity and body mass index (BMI).
“These results—to our knowledge the first of their kind—suggest that this and perhaps other correlations between gene variants and physical traits may vary significantly depending on when individuals were born, even for those born into the same families,” Harvard Medical School instructor James Niels Rosenquist, PhD, MD, of the Massachusetts General Hospital department of psychiatry and lead author of the report, said in a statement.
The researchers studied data gathered between 1971, on participants aged 27 to 63 years old, and 2008 in the Framingham Offspring Study. BMI was measured 8 times during the study period and the authors analyzed the relationship between BMI and the FTO variants inherited. They found that the association between the FTO variant and BMI was seen mostly in participants born in later years.
The authors did not identify environmental differences that combine with the gene variant to increase obesity risk, but they did not that increased reliance on technology and the availability of high-calorie processed foods that appeared post World War II were likely contributors.
According to the authors, the finding that global changes in the environment modify genetic risk factors adds a new dimension to gene-by environment interaction research. They added that genotype-phenotype correlations may depend on the historical moment in which investigations are conducted or the time period in which study subjects were born.
“We know that environment plays a huge role in the expression of genes, and the fact that our effect can be seen even among siblings born during different years implies that global environmental factors such as trends in food products and workplace activity, not just those found within families, may impact genetic traits,” says Rosenquist. “Our results underscore the importance of interpreting any genetic studies with a grain of salt and leave open the possibility that new genetic risk factors may be seen in the future due to different genetically driven responses to our ever-changing environment.”
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More